Cargando…
The Combination of the CDK4/6 Inhibitor, Palbociclib, With the Vitamin D(3) Analog, Inecalcitol, Has Potent In Vitro and In Vivo Anticancer Effects in Hormone-Sensitive Breast Cancer, But Has a More Limited Effect in Triple-Negative Breast Cancer
Active vitamin D(3), 1,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)], and its synthetically derived analogs possess potent anticancer properties. In breast cancer (BC) cells, 1,25(OH)(2)D(3) blocks cell proliferation and induces apoptosis through different cell-type specific mechanisms. In this study,...
Autores principales: | Vanhevel, Justine, Verlinden, Lieve, Loopmans, Shauni, Doms, Stefanie, Janssens, Iris, Bevers, Sien, Stegen, Steve, Wildiers, Hans, Verstuyf, Annemieke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248359/ https://www.ncbi.nlm.nih.gov/pubmed/35784555 http://dx.doi.org/10.3389/fendo.2022.886238 |
Ejemplares similares
-
The future of vitamin D analogs
por: Leyssens, Carlien, et al.
Publicado: (2014) -
Neuropilin 2 in osteoblasts regulates trabecular bone mass in male mice
por: Verlinden, Lieve, et al.
Publicado: (2023) -
Vitamin D Analogs Bearing C-20 Modifications Stabilize the Agonistic Conformation of Non-Responsive Vitamin D Receptor Variants
por: Belorusova, Anna Y., et al.
Publicado: (2022) -
Isolation and in vitro characterization of murine young-adult long bone skeletal progenitors
por: Loopmans, Shauni, et al.
Publicado: (2022) -
Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer
por: Durairaj, Chandrasekar, et al.
Publicado: (2018)